10x Genomics (TXG) Retained Earnings (2018 - 2026)

10x Genomics has disclosed Retained Earnings across 9 years of filings, most recently posting -$1.5 billion for Q2 2026.

• In Q2 2026, Retained Earnings fell 5.12% year-over-year to -$1.5 billion; the TTM figure through Jun 2026 stood at -$1.5 billion (down 5.12% YoY), while the FY2025 annual figure was -$1.5 billion, down 2.97% from the prior year.
• Retained Earnings came in at -$1.5 billion for Q2 2026 at 10x Genomics, down from -$1.5 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$905.7 million in Q1 2022 to a low of -$1.5 billion in Q2 2026.
• Average Retained Earnings over 5 years is -$1.3 billion, with a median of -$1.4 billion recorded in 2024.
• Year-over-year, Retained Earnings slipped 24.78% in 2023 and retreated 1.51% in 2026.
• Over 5 years, Retained Earnings stood at -$1.0 billion in 2022, then fell by 24.78% to -$1.3 billion in 2023, then declined by 14.22% to -$1.5 billion in 2024, then retreated by 2.97% to -$1.5 billion in 2025, then slipped by 2.08% to -$1.5 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$1.5 billion in Q2 2026, -$1.5 billion in Q1 2026, and -$1.5 billion in Q4 2025.